@tamsenfadal's menopause hormone advice, fact-checked
Quick answer
Fadal describes a common clinical scenario in perimenopausal hormone therapy: breakthrough symptoms despite adherence to a standard 0.05 mg/day transdermal estradiol patch, confirmed by lab values showing inadequate serum estradiol levels, prompting an evidence-supported dose increase to 0.075 mg/day. Concurrent vitamin D deficiency, a frequent comorbidity in this population, was also identified and is being treated with high-dose weekly supplementation (almost certainly 50,000 IU, not milligrams as stated). Her oral progesterone use for sleep support aligns with published data on micronized progesterone's sedative properties.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @tamsenfadal actually say?
Tamsen Fadal describes feeling "off" despite being on a 0.05 mg/day estradiol patch applied twice weekly, plus oral progesterone nightly for sleep. Bloodwork revealed her body "was not absorbing" the estrogen. Her doctor also found she had "zero vitamin D" and prescribed 50,000 IU weekly (she said milligrams, but the correct unit is IU). Her estradiol dose was bumped to 0.075 mg/day. The main message: trust your symptoms, get tested, advocate for yourself.
This is a personal health update, not a prescriptive how-to video. She is not telling viewers what dose to take. That matters when evaluating whether this content is responsible, and largely it is.
Does the science back this up?
Yes, transdermal estradiol absorption varies significantly between individuals, and that is not fringe opinion. It is well-documented in pharmacokinetic research. The dose adjustment she describes, moving from 0.05 mg to 0.075 mg, is a standard clinical step supported by prescribing guidelines.
A study by Strasser and colleagues (2018, Climacteric) confirmed that transdermal estradiol serum levels vary substantially across patients using identical patches, due to differences in skin hydration, body composition, application site, and age-related skin changes. Application on the hip versus abdomen also produces measurable differences in absorption. Faubion et al. (2020, Mayo Clinic Proceedings) noted that monitoring serum estradiol levels is appropriate when patients report symptom breakthrough despite apparent adherence to therapy. The North American Menopause Society's 2022 position statement supports dose titration based on symptom response and lab values, which is exactly what her doctor did.
What did they get wrong (or right)?
One factual error stands out: she says her doctor prescribed "50,000 milligrams" of vitamin D weekly. The correct unit is 50,000 IU (international units). Fifty thousand milligrams of anything would be 50 grams, which is a nonsensical and dangerous dose. This is almost certainly a verbal slip, not a dangerous recommendation, but it is worth correcting clearly.
On the estrogen side, she gets the mechanics right. Patch strength, application sites, and twice-weekly scheduling are accurate for the Vivelle-Dot and generic equivalents. Oral micronized progesterone (likely Prometrium or a generic) is legitimately associated with improved sleep quality. Hitchcock and Prior (2012, Climacteric) found that 300 mg oral micronized progesterone improved sleep in perimenopausal women, supporting her observation. She does not overclaim here. She says it makes her sleep well, not that it cures insomnia.
She also avoids the common influencer trap of telling viewers to copy her regimen. She explicitly says "go and get that checked," not "switch to a higher dose patch." That is the right call.
What should you actually know?
Transdermal hormone absorption is genuinely variable, and symptom persistence on HRT is not always a compliance problem. Patients who feel "off" despite following their protocol are not imagining things. Serum estradiol testing is a legitimate clinical tool to distinguish non-absorption from undertreating.
Vitamin D deficiency is extremely common in perimenopausal and postmenopausal women and interacts with mood, fatigue, and musculoskeletal symptoms in ways that can mimic or worsen estrogen-deficiency symptoms. Bischoff-Ferrari et al. (2009, BMJ) documented the high prevalence of deficiency in this demographic. Getting both checked at the same visit, as her doctor did, is good clinical practice.
One important caveat: self-monitoring on social media creates pressure to interpret normal transitional symptoms as treatment failure. Not every period of feeling "off" requires a dose increase. That judgment belongs with a clinician who has your full picture, not a TikTok comment section.
Bottom line
This video is more responsible than most HRT content on TikTok. Fadal does not prescribe, does not claim her protocol is universal, and explicitly redirects viewers to their own doctors. The vitamin D unit error is minor but should be corrected. The broader message, that symptom-driven blood work is worth doing when something feels wrong, is clinically sound and supported by current menopause management guidelines.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @tamsenfadal's menopause hormone advice, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@tamsenfadal's menopause hormone advice, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Fadal describes a common clinical scenario in perimenopausal hormone therapy: breakthrough symptoms despite adherence to a standard 0.
FormBlends verdict
Fadal describes a common clinical scenario in perimenopausal hormone therapy: breakthrough symptoms despite adherence to a standard 0.05 mg/day transdermal estradiol patch, confirmed by lab values showing inadequate serum estradiol levels, prompting an evidence-supported dose increase to 0.075 mg/day. Concurrent vitamin D deficiency, a frequent comorbidity in this population, was also identified and is being treated with high-dose weekly supplementation (almost certainly 50,000 IU, not milligrams as stated). Her oral progesterone use for sleep support aligns with published data on micronized progesterone's sedative properties.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Fadal describes a common clinical scenario in perimenopausal hormone therapy: breakthrough symptoms despite adherence to a standard 0.05 mg/day transdermal estradiol patch, confirmed by lab values showing inadequate serum estradiol levels, prompting an evidence-supported dose increase to 0.075 mg/day. Concurrent vitamin D deficiency, a frequent comorbidity in this population, was also identified and is being treated with high-dose weekly supplementation (almost certainly 50,000 IU, not milligrams as stated). Her oral progesterone use for sleep support aligns with published data on micronized progesterone's sedative properties.
- Transdermal estradiol absorption varies significantly between patients on the same dose; serum estradiol testing is appropriate when symptoms persist despite adherence (Strasser et al., 2018, Climacteric).
- The 0.05 mg and 0.075 mg/day estradiol patch strengths she references are real, FDA-approved doses, and titration between them is standard clinical practice per NAMS 2022 guidelines.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Transdermal estradiol absorption varies significantly between patients on the same dose; serum estradiol testing is appropriate when symptoms persist despite adherence (Strasser et al., 2018, Climacteric).
- The 0.05 mg and 0.075 mg/day estradiol patch strengths she references are real, FDA-approved doses, and titration between them is standard clinical practice per NAMS 2022 guidelines.
- Oral micronized progesterone has documented sleep-promoting effects in perimenopausal women at doses of 300 mg, supported by Hitchcock and Prior (2012, Climacteric), consistent with her experience.
- Vitamin D deficiency is common in perimenopausal women and can produce fatigue and mood symptoms that overlap with estrogen deficiency; Bischoff-Ferrari et al. (2009, BMJ) documented the high prevalence in this demographic.
- The '50,000 milligrams' vitamin D dose she describes is a unit error. The correct unit is 50,000 IU, a legitimate weekly prescription dose for deficiency. Fifty thousand milligrams does not exist as a real prescription.
- Her core message, get bloodwork done when something feels wrong rather than assuming it is fine, aligns with current menopause management guidance and is responsible advice for a social media audience.
- She explicitly tells viewers to see their own doctor rather than copy her regimen, which distinguishes this video from more problematic HRT content that provides de facto prescribing guidance.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Tamsen Fadal · TikTok creator
267.0K views on this video
Always trust your gut! #menopause #estrogen #progesterone #hrt
Sources & references
- [1]Faubion et al. (2020)
- [2]Bischoff-Ferrari et al. (2009)
- [3]Strasser and colleagues (2018)
- [4]Hitchcock and Prior (2012)
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Tamsen Fadal, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.